Apostolidis, Leonidas
Lang, Kristin
Sisic, Leila
Busch, Elena
Ahadova, Aysel
Wullenkord, Ramona
Nienhüser, Henrik
Billeter, Adrian
Müller-Stich, Beat
Kloor, Matthias
Jaeger, Dirk
Haag, Georg Martin http://orcid.org/0000-0002-9410-9968
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 24 February 2022
Accepted: 4 April 2022
First Online: 19 April 2022
Declarations
:
: GMH received fees for an advisory role from Bristol-Myers Squibb, MSD Sharp & Dohme, Lilly and Novartis. He received speaker´s honoraria from Servier, MSD Sharp & Dohme, Lilly, Targos, Bristol-Myers Squibb and Iomedico and MCI Conventions. He received research funding from Nordic Pharma, Taiho Pharmaceutical, MSD Sharp & Dohme, Bristol-Myers Squibb, Janssen, IKF Klinische Krebsforschung Frankfurt, Astra Zeneca. Travel and Accommodations were provided by Bristol-Myers Squibb, Lilly, Servier, MSD Sharp & Dohme. DJ reports Consulting fees for advisory role from CureVac AG, Definiens, F. Hoffmann-La Roche Ltd, Genmab A-S, Life Science Inkubator GmbH, VAXIMM AG, OncoOne Research & Development Research GmbH, Oncoloytics Biotech Inc; he received payments or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from SKK Kliniken Heilbronn GmbH, Georg Thieme Verlag, Terrapinn, Touch Medical Media, BMS GmbH & Co KGaA, MSD; he received payment for expert testimony from Wilhelm-Sander Stiftung, Else-Kröner-Fesenius-Stiftung, Schering Stiftung, NordForsk and support for attending meetings and/or travel from Amgen Inc, Oryx GmbH, Roche Glycart AG, Parexel.com, IKTZ HD GmbH, BMS. He has a leadership or fiduciary role in BMS Stiftung Immunonkologie.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University Heidelberg.